Abstract
Rheumatoid arthritis (RA) is a systemic autoimmune and inflammatory disease that mainly alters the synovial joints and ultimately leads to their destruction. The involvement of the immune system and its related cells is a basic trademark of autoimmune-associated diseases. The present work focuses on network analysis and its functional characterization to predict novel targets for RA. The interactive model called as rheumatoid arthritis drug–target–protein (RA-DTP) is built of 1727 nodes and 7954 edges followed the power-law distribution. RA-DTP comprised of 20 islands, 55 modules and 123 submodules. Good interactome coverage of target–protein was detected in island 2 (Q-Score 0.875) which includes 673 molecules with 20 modules and 68 submodules. The biological landscape of these modules was examined based on the participation molecules in specific cellular localization, molecular function and biological pathway with favourable p value. Functional characterization and pathway analysis through KEGG, Biocarta and Reactome also showed their involvement in relation to the immune system and inflammatory processes and biological processes such as cell signalling and communication, glucosamine metabolic process, renin–angiotensin system, BCR signals, galactose metabolism, MAPK signalling, complement and coagulation system and NGF signalling pathways. Traffic values and centrality parameters were applied as the selection criteria for identifying potential targets from the important hubs which resulted into FOS, KNG1, PTGDS, HSP90AA1, REN, POMC, FCER1G, IL6, ICAM1, SGK1, NOS3 and PLA2G4A. This approach provides an insight into experimental validation of these associations of potential targets for clinical value to find their effect on animal studies.
Similar content being viewed by others
References
McInnes IB, Schett G (2011) The pathogenesis of rheumatoid arthritis. N Engl J Med 365:2205–2219
Singh S, Vennila JJ (2014) Gene expression profiling for identifying key role of synovial macrophages in rheumatoid arthritis. Int J Comput Bioinfo In Silico Model 3:332–336
Manju S, Chandankhede, Madhur M, Gupta (2013) Oxidative stress and antioxidant status in patients with rheumatoid arthritis. Int J Biol Med Res 4:3088–3090
Arrell DK, Terzic A (2010) Network systems biology for drug discovery. Clin Pharmacol Ther 88:120–125
Hopkins AL (2008) Network pharmacology: the next paradigm in drug discovery. Nat Chem Biol 4:682–690. doi:10.1038/nchembio.118
Salwinski L, Licata L, Winter A, Thorneycroft D, Khadake J, Ceol A, Aryamontri AC, Oughtred R, Livstone M, Boucher L, Botstein D, Dolinski K, Berardini T, Huala E, Tyers M, Eisenberg D, Cesareni G, Hermjakob H (2009) Recurated protein interaction datasets. Nat Methods 6:860–861. doi:10.1038/nmeth1209-860
Cline MS, Smoot M, Cerami E, Kuchinsky A, Landys N, Workman C, Christmas R, Avila CI, Creech M, Gross B, Hanspers K, Isserlin R, Kelley R, Killcoyne S, Lotia S, Maere S, Morris J, Ono K, Pavlovic V, Pico AR, Vailaya A, Wang PL, Adler A, Conklin BR, Hood L, Kuiper M, Sander C, Schmulevich I, Schwikowski B, Warner GJ, Ideker T, Bader GD (2007) Integration of biological networks and gene expression data using Cytoscape. Nat Protoc 2:2366–2382
Lima MG, Van HJ (2009) The powerful law of the power law and other myths in network biology. Mol Biosyst 5:1482–1493
Diestel R (2005) Graph theory, ser. Graduate texts in mathematics, 173rd edn. Springer, Heidelberg
Azuaje FJ, Zhang L, Devaux Y, Wagner DR (2011) Drug-target network in myocardial infarction reveals multiple side effects of unrelated drugs. Sci Rep 1. doi:10.1038/srep00052
Maslov S, Sneppen K (2002) Specificity and stability in topology of protein networks. Science 296:910–913. doi:10.1126/science.1065103
Snijesh VP, Singh S (2014) Molecular modeling and network based approach in explaining the medicinal properties of nyctanthes arbortristis, lippia nodiflora for rheumatoid arthritis. J Bioinf Intell Control 3:31–38. doi:10.1166/jbic.2014.1072
Watts DJ, Strogatz SH (1998) Collective dynamics of ’small-world’ networks. Nature 393:440–442. doi:10.1038/30918
Al-Shahrour F, Díaz-Uriarte R, Dopazo J (2004) FatiGO: a web tool for finding significant associations of Gene Ontology terms with groups of genes. Bioinformatics 20:578–580
Goncalves JP, Graos M, Valente AX (2009) Polar mapper: a computational tool for integrated visualization of protein interaction networks and mRNA expression data. J R Soc Interface 6:881–896. doi:10.1098/rsif.2008.0407
Valente AX, Cusick ME (2006) Yeast protein interactome topology provides framework for coordinated-functionality. Nucleic Acids Res 34:2812–2819
Hartwell LH, Hopfield JJ, Leibler S, Murray AW (1999) From molecular to modular cell biology. Nature 402:47–51
Rajendran L, Knölker HJ, Simons K (2010) Subcellular targeting strategies for drug design and delivery. Nat Rev Drug Discov 9:29–42. doi:10.1038/nrd2897
Crofford LJ, Wilder RL, Ristimäki AP, Sano H, Remmers EF, Epps HR, Hla T (1994) Cyclooxygenase-1 and-2 expression in rheumatoid synovial tissues. Effects of interleukin-1 beta, phorbol ester, and corticosteroids. J Clin Invest 93:1095–1101. doi:10.1172/JCI117060
Klareskog L, McDevitt H (1999) Rheumatoid arthritis and its animal models: the role of TNF-\(\alpha\) and the possible absence of specific immune reactions. Curr Opin Immunol 11:657–662
Ultaigh SN, Saber TP, McCormick J, Connolly M, Dellacasagrande J, Keogh B, Veale DJ (2011) Blockade of Toll-like receptor 2 prevents spontaneous cytokine release from rheumatoid arthritis ex vivo synovial explant cultures. Arthritis Res Ther 13:33–33
Paravicini TM, Yogi A, Mazur A, Touyz RM (2009) Dysregulation of vascular TRPM7 and annexin-1 is associated with endothelial dysfunction in inherited hypomagnesemia. Hypertension 53:423–429
Adam O, Beringer C, Kless T, Lemmen C, Adam A, Wiseman M, Forth W (2003) Anti-inflammatory effects of a low arachidonic acid diet and fish oil in patients with rheumatoid arthritis. Rheumatol Int 23:27–36
Inoue H, Takamori M, Nagata N, Nishikawa T, Oda H, Yamamoto S, Koshihara Y (2001) An investigation of cell proliferation and soluble mediators induced by interleukin 1\(\beta\) in human synovial fibroblasts: comparative response in osteoarthritis and rheumatoid arthritis. Inflamm Res 50:65–72
Germain P, Staels B, Dacquet C, Spedding M, Laudet V (2006) Overview of nomenclature of nuclear receptors. Pharmacol Rev 58:685–704. doi:10.1124/pr.58.4.2
Visel A, Blow MJ, Li Z, Zhang T, Akiyama JA, Holt A, Plajzer-Frick I, Shoukry M, Wright C, Chen F, Afzal V, Ren B, Rubin EM, Pennacchio LA (2009) ChIP-seq accurately predicts tissue-specific activity of enhancers. Nature 457:854–858. doi:10.1038/nature07730
Zoll J, Monassier L, Garnier A, N’Guessan B, Mettauer B, Veksler V, Piquard F, Ventura-Clapier R, Geny B (2006) ACE inhibition prevents myocardial infarction-induced skeletal muscle mitochondrial dysfunction. Appl Physiol 101:385–391. doi:10.1152/japplphysiol.01486.2005
Anzenbacher P, Anzenbacherova E (2001) Cytochromes P450 and metabolism of xenobiotics. Cell Mol Life Sci 58:737–747
Halazonetis TD, Georgopoulos K, Greenberg ME, Leder P (1988) c-Jun dimerizes with itself and with c-Fos, forming complexes of different DNA binding affinities. Cell 55:917–924
Johnston SR, Lu B, Scott GK, Kushner PJ, Smith IE, Dowsett M, Benz CC (1999) Increased activator protein-1 DNA binding and c-Jun NH2-terminal kinase activity in human breast tumors with acquired tamoxifen resistance. Clin Cancer Res 5:251–256
Liedtke W (2008) Molecular mechanisms of TRPV4-mediated neural signaling. Ann N Y Acad Sci 1144:42–52
Okuse K (2007) Pain signalling pathways: from cytokines to ion channels. Int J Biochem Cell Biol 39:490–496
Tremblay L, Valenza F, Ribeiro SP, Li J, Slutsky AS (1997) Injurious ventilatory strategies increase cytokines and c-fos m-RNA expression in an isolated rat lung model. J Clin Invest 99:944–952. doi:10.1172/JCI119259
Kavelaars A, Ballieux RE, Heijnen CJ (1989) The role of IL-1 in the corticotropin-releasing factor and arginine-vasopressin-induced secretion of immunoreactive \(\beta\)-endorphin by human peripheral blood mononuclear cells. J Immunol 142:2338–2342
Kavelaars A, Berkenbosch F, Croiset G, Ballieux RE, Heijnen CJ (1990) Induction of \(\beta\)-endorphin secretion by lymphocytes after subcutaneous administration of corticotropin-releasing factor. Endocrinology 126:759–764
Smith EM, Morrill AC, Meyer WJ, Blalock JE (1986) Corticotropin releasing factor induction of leukocyte-derived immunoreactive ACTH and endorphins. Nature 321:881–882
Wen JJ, Zago MP, Nunez S, Gupta S, Burgos FN, Garg NJ (2012) Serum proteomic signature of human chagasic patients for the identification of novel potential protein biomarkers of disease. Mol Cell Proteomics 11:435–452
Mosén H, Salehi A, Henningsson R, Lundquist I (2006) Nitric oxide inhibits, and carbon monoxide activates, islet acid \(\alpha\)-glucoside hydrolase activities in parallel with glucose-stimulated insulin secretion. J Endocrinol 190:681–693
Uehara T, Park JT (2004) The N-acetyl-D-glucosamine kinase of Escherichia coli and its role in murein recycling. J Bacteriol 186:7273–7279. doi:10.1128/JB.186.21.7273-7279.2004
Murrell MP, Yarema KJ, Levchenko A (2004) The systems biology of glycosylation. Chem Bio Chem 5:1334–1347
Acknowledgments
This research work was supported and funded by Science and Engineering Research Board—Department of Science and Technology (SERB-DST) and Karunya University
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Singh, S., Vennila, J.J., Snijesh, V.P. et al. Implying Analytic Measures for Unravelling Rheumatoid Arthritis Significant Proteins Through Drug–Target Interaction. Interdiscip Sci Comput Life Sci 8, 122–131 (2016). https://doi.org/10.1007/s12539-015-0108-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12539-015-0108-9